busulfan kabi injection 6mgml concentrate for solution for infusion
fresenius kabi malaysia sdn. bhd - busulfan -
bortezomib fresenius kabi 3.5 mg
neopharm (israel) 1996 ltd - bortezomib - powder for solution for injection - bortezomib 3.5 mg/vial - bortezomib - multiple myelomabortezomib fresenius kabi is indicated for the treatment of adult patients with multiple myeloma.mantle cell lymphomabortezomib fresenius kabi for injection is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. bortezomib fresenius kabi in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.
temozam 20 capsules 20mg
fresenius kabi malaysia sdn. bhd - temozolomide -
temozam 100mg capsules
fresenius kabi malaysia sdn. bhd - temozolomide -
fludarabine kabi 50mg lyophilized powder for solution for injection or infusion
fresenius kabi malaysia sdn. bhd - fludarabine phosphate -
trozet tablets 2.5mg
fresenius kabi malaysia sdn. bhd - letrozole -
vinelbine injection-10mgml
fresenius kabi malaysia sdn. bhd - vinorelbine tartrate -
etoposide 20 mg/ml concentrate for solution for infusion
fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - 20 milligram(s)/millilitre - podophyllotoxin derivatives; etoposide
irinotecan hydrochloride 20 mg/ml concentrate for
fresenius kabi oncology plc - irinotecan hydrochloride trihydrate - solution for infusion - 20 micromol - irinotecan
bendamustine hcl
fresenius kabi oncology plc - bendamustine hydrochloride - pdr/conc/soln for infus - 25 milligram - bendamustine